One Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.74M Sell
51,982
-9,699
-16% -$937K 0.13% 132
2026
Q2
$3.99M Hold
61,681
– – 0.11% 142
2026
Q1
$3.99M Buy
61,681
+14,875
+32% +$1.05M 0.11% 143
2025
Q4
$3.15M Buy
46,806
+13,248
+39% +$891K 0.1% 141
2025
Q3
$2.46M Buy
33,558
+11,557
+53% +$768K 0.08% 142
2025
Q2
$1.14M Buy
+22,001
New +$1.25M 0.04% 201
2023
Q4
– Sell
-10,075
Closed -$385K – 292
2023
Q3
$385K Hold
10,075
– – 0.02% 212
2023
Q2
$363K Hold
10,075
– – 0.02% 226
2023
Q1
$385K Hold
10,075
– – 0.02% 234
2022
Q4
$573K Sell
10,075
-2,125
-17% -$109K 0.03% 199
2022
Q3
$482K Hold
12,200
– – 0.03% 212
2022
Q2
$536K Hold
12,200
– – 0.03% 207
2022
Q1
$486K Hold
12,200
– – 0.03% 226
2021
Q4
$490K Sell
12,200
-29
-0.2% -$1.08K 0.04% 181
2021
Q3
$497K Sell
12,229
-12,000
-50% -$502K 0.04% 153
2021
Q2
$1.1M Buy
+24,229
New +$1.07M 0.1% 123

Other funds holding HALO

One Capital Management's HALO Position: Q3 2026 in Review

One Capital Management reduced its Halozyme (HALO) stake by 16% in Q3 2026, selling an estimated $937K and leaving 51,982 shares worth $5.74M. The position accounts for 0.13% of the portfolio, ranked #132.

One Capital Management first reported a position in HALO in Q2 2021 and has held it in 16 quarters since. 770 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • One Capital Management held 51,982 shares of Halozyme worth $5.74M as of Q3 2026.
  • One Capital Management sold 9,699 Halozyme shares in Q3 2026, an estimated $937K.
  • Halozyme made up 0.13% of One Capital Management's portfolio in Q3 2026, its #132 holding.
  • One Capital Management first reported a position in Halozyme in Q2 2021 and has held it in 16 quarters since.
  • 770 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on One Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.